The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Melaena 3
SANDOSTATIN LAR DEPOT Menstruation delayed 3
SANDOSTATIN LAR DEPOT Menstruation irregular 3
SANDOSTATIN LAR DEPOT Metastases to thyroid 3
SANDOSTATIN LAR DEPOT Mitral valve disease 3
SANDOSTATIN LAR DEPOT Multiple sclerosis 3
SANDOSTATIN LAR DEPOT Nerve injury 3
SANDOSTATIN LAR DEPOT Neuroendocrine carcinoma 3
SANDOSTATIN LAR DEPOT Non-small cell lung cancer 3
SANDOSTATIN LAR DEPOT Nose deformity 3
SANDOSTATIN LAR DEPOT Oral discomfort 3
SANDOSTATIN LAR DEPOT Ovarian mass 3
SANDOSTATIN LAR DEPOT Palmar-plantar erythrodysaesthesia syndrome 3
SANDOSTATIN LAR DEPOT Pancreatic enzymes decreased 3
SANDOSTATIN LAR DEPOT Pancreatolithiasis 3
SANDOSTATIN LAR DEPOT Panic disorder 3
SANDOSTATIN LAR DEPOT Periarticular disorder 3
SANDOSTATIN LAR DEPOT Pharyngeal oedema 3
SANDOSTATIN LAR DEPOT Pituitary tumour 3
SANDOSTATIN LAR DEPOT Pneumonia bacterial 3

Total Records: 2,045     Number of Pages: 103